Patents by Inventor Michael Otteneder

Michael Otteneder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cinnamic acid amides
    Publication number: 20090149528
    Abstract: The present invention relates to compounds, to processes for preparing them, to pharmaceutical compositions comprising them, and to their use in the therapy and/or prophylaxis in illnesses in people or animals, especially diseases of bacterial infection.
    Type: Application
    Filed: July 2, 2008
    Publication date: June 11, 2009
    Applicant: Bayer HealthCare AG
    Inventors: Nina Brunner, Christoph Freiberg, Thomas Lampe, Ben Newton, Michael Otteneder, Joseph Pernerstorfer, Jens Pohlmann, Guido Schiffer, Mitsuyuki Shimada, Niels Svenstrup, Rainer Endermann, Peter Nell
  • Derivatives of andrimide and moiramide B having antibacterial properties
    Patent number: 7544709
    Abstract: The invention relates to compounds of general formula (I), to a method for the production thereof, to pharmaceutical compositions containing them, and to their use in the treatment and/or prophlaxis of diseases in humans or animals, particularly bacterial infections diseases. The compounds are derivatives of the natural substances andrimide and moiramide B.
    Type: Grant
    Filed: November 7, 2002
    Date of Patent: June 9, 2009
    Assignee: Bayer Healthcare AG
    Inventors: Nina Brunner, Christoph Freiberg, Thomas Lampe, Ben Newton, Michael Otteneder, Josef Pernerstorfer, Jens Pohlmann, Guido Schiffer, Mitsuyuki Shimada
  • Cinnamic acid amides
    Patent number: 7402683
    Abstract: The present invention relates to compounds, to processes for preparing them, to pharmaceutical compositions comprising them, and to their use in the therapy and/or prophylaxis in illnesses in people or animals, especially diseases of bacterial infection.
    Type: Grant
    Filed: April 14, 2003
    Date of Patent: July 22, 2008
    Assignee: Bayer HealthCare AG
    Inventors: Nina Brunner, Christoph Freiberg, Thomas Lampe, Ben Newton, Michael Otteneder, Josef Pernerstorfer, Jens Pohlmann, Guido Schiffer, Mitsuyuki Shimada, Niels Svenstrup, Rainer Endermann, Peter Nell
  • Arylamides
    Patent number: 7348357
    Abstract: The present invention relates to compounds, to processes for preparing them, to pharmaceutical compositions comprising them, and to their use in the therapy and/or prophylaxis of diseases in people or animals, especially diseases of bacterial infection.
    Type: Grant
    Filed: July 28, 2003
    Date of Patent: March 25, 2008
    Assignee: Bayer HealthCare AG
    Inventors: Nina Brunner, Christoph Freiberg, Thomas Lampe, Peter Nell, Ben Newton, Michael Otteneder, Josef Pernerstorfer, Jens Pohlmann, Guido Schiffer, Mitsuyuki Shimada, Niels Svenstrup, Rainer Endermann
  • Indole-phenylsulfonamide derivatives used as ppar-delta activating compounds
    Publication number: 20070149514
    Abstract: The invention relates to novel indole-phenylfulfonamide derivatives, to methods for the production thereof, and to their use in medicaments, particularly as potent PPAR-delta activating compounds, for the prevention and/or treatment of cardiovascular diseases, particularly dyslipidemias and coronary heart diseases.
    Type: Application
    Filed: December 24, 2003
    Publication date: June 28, 2007
    Applicant: Bayer HealthCare AG
    Inventors: Michael Woltering, Hilmar Bischoff, Elke Dittrich-Wengenroth, Heike Heckroth, Michael Otteneder
  • Cinnamic acid amides
    Publication number: 20060178369
    Abstract: The present invention relates to compounds, to processes for preparing them, to pharmaceutical compositions comprising them, and to their use in the therapy and/or prophylaxis in illnesses in people or animals, especially diseases of bacterial infection.
    Type: Application
    Filed: April 14, 2003
    Publication date: August 10, 2006
    Inventors: Nina Brunner, Christoph Freiberg, Thomas Lampe, Ben Newton, Michael Otteneder, Josef Pernerstorfer, Jens Pohlmann, Guido Schiffer, Mitsuyuki Shimada, Niels Svenstrup, Rainer Endermann
  • Arylamides
    Publication number: 20060173040
    Abstract: The present invention relates to compounds, to processes for preparing them, to pharmaceutical compositions comprising them, and to their use in the therapy and/or prophylaxis of diseases in people or animals, especially diseases of bacterial infection.
    Type: Application
    Filed: July 28, 2003
    Publication date: August 3, 2006
    Applicant: Bayer HealthCare AG
    Inventors: Nina Brunner, Christoph Freiberg, Thomas Lampe, Peter Nell, Ben Newton, Michael Otteneder, Josef Pernerstorfer, Jens Pohlmann, Guido Schiffer, Mitsuyuki Shimada, Niels Svenstrup, Rainer Endermann
  • Indolin phenylsulfonamide derivatives
    Publication number: 20060100230
    Abstract: The invention relates to novel substituted indolin phenylsulfonamide derivatives, to a method for the production thereof and to the use thereof in medicaments, especially as potent PPAR-delta activating compounds for the prophylaxis and/or treatment of cardiovascular diseases, especially dyslipidaemia and coronary heart diseases.
    Type: Application
    Filed: June 30, 2003
    Publication date: May 11, 2006
    Inventors: Hilmar Bischoff, Elke Dittrich-Wengenroth, Martina Wuttke, Heike Heckroth, Wolfgang Thielemann, Michael Woltering, Michael Otteneder
  • Piperidine ouracil used as a medicament for treating bacterial infections
    Publication number: 20060100224
    Abstract: The invention relates to piperidine ouracil and a method for the production thereof in addition to the use thereof in the production of medicaments for treating and/or in the prophylaxis of diseases, especially bacterial diseases.
    Type: Application
    Filed: February 13, 2003
    Publication date: May 11, 2006
    Inventors: Niels Svenstrup, Alexander Kuhl, Dietmar Flubacher, Michael Brands, Kerstin Ehlert, Christoph Ladel, Michael Otteneder, Jorg Keldenich
  • Tetrahydroisoquinoline derivatives
    Publication number: 20050234096
    Abstract: The invention relates to novel substituted tetrahydroisoquinoline derivatives, methods for the production thereof and the use thereof in medicaments, especially as potent PPAR-delta activating compounds for the prophylaxis and/or treatment of cardiovascular diseases, especially dislipidaemia, coronary heart disease and arteriosclerosis.
    Type: Application
    Filed: May 5, 2003
    Publication date: October 20, 2005
    Inventors: Hilmar Bischoff, Elke Dittrich-Wengenroth, Verena Vohringer, Heike Heckroth, Andrea Vaupel, Michael Woltering, Michael Otteneder
  • Derivatives of andrimide and moiramide b having antibacterial properties
    Publication number: 20050080129
    Abstract: The invention relates to compounds of general formula (I), to a method for the production thereof, to pharmaceutical compositions containing them, and to their use in the treatment and/or prophlaxis of diseases in humans or animals, diseases. The compounds are derivatives of the natural substances andrimide and moiramide B.
    Type: Application
    Filed: November 7, 2002
    Publication date: April 14, 2005
    Applicant: Bayer HealthCare AG
    Inventors: Nina Brunner, Christoph Freiberg, Thomas Lampe, Ben Newton, Michael Otteneder, Josef Pernerstorfer, Jens Pohlmann, Guido Shiffer, Mitsuyuki Shimada